(CNN) -- Kerry Morgan was just 3 years old when she participated in her first clinical trial for type 1 diabetes prevention. She didn't have the disease, but her 7-year old sister did and there was concern that she might develop it, too. During the trial she was given one shot of insulin a day in the hope that it would stave off the disease, but a year later, she was officially diagnosed.
"I remember a lot of things changed." Morgan said. "I went from having juice every day and M&Ms to not having sugar at all. I remember getting shots every day, finger pricks, my parents had to hold me down."
School, she says was difficult. "You had to let teachers know what was going on. You had a special relationship with the nurse because she had to check your blood sugar every day before going to lunch."
At 14 she entered a second trial, this one at the University of Virginia, for a continuous glucose monitoring system called The Navigator. It was at UVA that she first learned about the artificial pancreas. A high school senior at 18 now, she has participated in four clinical trials and two have involved artificial pancreas systems.